SE8302075L - Vasopressin-analoger - Google Patents

Vasopressin-analoger

Info

Publication number: SE8302075L
Authority: SE; Sweden
Prior art keywords: vasopressin; arg; analogs; compounds; residue
Prior art date: 1982-04-20

Application number

SE8302075A

Other languages

English (en)

Other versions

SE460050B (sv

SE8302075D0 (sv

Inventor

F Brtnik

T Barth

P Hrbas

K Jost

I Krejci

B Kupkova

A Machova

L Servitova

J Skopkova

Original Assignee

Ceskoslovenska Akademie Ved

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-04-20

Filing date

1983-04-14

Publication date

1983-10-21

1982-04-20 Priority claimed from CS822803A external-priority patent/CS230315B1/cs

1982-11-19 Priority claimed from CS830182A external-priority patent/CS231749B1/cs

1983-04-14 Application filed by Ceskoslovenska Akademie Ved filed Critical Ceskoslovenska Akademie Ved

1983-04-14 Publication of SE8302075D0 publication Critical patent/SE8302075D0/sv

1983-10-21 Publication of SE8302075L publication Critical patent/SE8302075L/sv

1989-09-04 Publication of SE460050B publication Critical patent/SE460050B/sv

Links

125000002038 D-arginyl group Chemical group N[C@@H](C(=O)*)CCCNC(=N)N 0.000 abstract 2
KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical class C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
230000000694 effects Effects 0.000 abstract 2
ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 abstract 1
229930064664 L-arginine Natural products 0.000 abstract 1
235000014852 L-arginine Nutrition 0.000 abstract 1
DBTDEFJAFBUGPP-UHFFFAOYSA-N Methanethial Chemical group S=C DBTDEFJAFBUGPP-UHFFFAOYSA-N 0.000 abstract 1
AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Chemical group NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 abstract 1
GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 abstract 1
102000002852 Vasopressins Human genes 0.000 abstract 1
108010004977 Vasopressins Proteins 0.000 abstract 1
210000003169 central nervous system Anatomy 0.000 abstract 1
238000003776 cleavage reaction Methods 0.000 abstract 1
230000002124 endocrine Effects 0.000 abstract 1
230000002255 enzymatic effect Effects 0.000 abstract 1
BEBCJVAWIBVWNZ-UHFFFAOYSA-N glycinamide Chemical group NCC(N)=O BEBCJVAWIBVWNZ-UHFFFAOYSA-N 0.000 abstract 1
AHLPHDHHMVZTML-BYPYZUCNSA-N ornithyl group Chemical group N[C@@H](CCCN)C(=O)O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 abstract 1
230000002093 peripheral effect Effects 0.000 abstract 1
230000007017 scission Effects 0.000 abstract 1
229960003726 vasopressin Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/15—Oxytocin or vasopressin; related peptides

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Life Sciences & Earth Sciences (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

SE8302075A 1982-04-20 1983-04-14 Vasopressinanaloger med effekter paa det centrala nervsystemet SE460050B (sv)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CS822803A CS230315B1 (cs)	1982-04-20	1982-04-20	Analogy vasopresinu a způsob jejich výroby
CS830182A CS231749B1 (cs)	1982-11-19	1982-11-19	Analog vasopresinu a způsob jeho výroby

Publications (3)

Publication Number	Publication Date
SE8302075D0 SE8302075D0 (sv)	1983-04-14
SE8302075L true SE8302075L (sv)	1983-10-21
SE460050B SE460050B (sv)	1989-09-04

Family

ID=25745688

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE8302075A SE460050B (sv)	1982-04-20	1983-04-14	Vasopressinanaloger med effekter paa det centrala nervsystemet

Country Status (11)

Country	Link
US (1)	US4482486A (sv)
JP (1)	JPS6485999A (sv)
BE (1)	BE896504A (sv)
CH (1)	CH653345A5 (sv)
DE (1)	DE3314357A1 (sv)
DK (1)	DK153883A (sv)
FR (1)	FR2525215B1 (sv)
GB (1)	GB2121049B (sv)
IT (1)	IT1164189B (sv)
NL (1)	NL8301320A (sv)
SE (1)	SE460050B (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4714696A (en) *	1984-01-26	1987-12-22	Medical College Of Ohio	Novel derivatives of arginine vasopressin antagonists
CA1249397A (en) *	1984-03-07	1989-01-24	Fadia E. Ali	Process for preparing des-proline vasopressin antagonists
US4661472A (en) *	1985-05-09	1987-04-28	The Salk Institute For Biological Studies	GnRH antagonists IX
US4711877A (en) *	1985-09-18	1987-12-08	Smithkline Beckman Corporation	6-pen-vasopressin compounds
US4760052A (en) *	1986-01-16	1988-07-26	Smithkline Beckman Corporation	1,6-dicarba-vasopressin compounds
US6028168A (en)	1991-08-09	2000-02-22	Winfried Kolbeck	Lanthionine bridged peptides
US5562812A (en) *	1995-04-03	1996-10-08	The Penn State Research Foundation	Free flow electrophoresis device for biomolecule purification and separation in zero and one G
US6903075B1 (en)	1997-05-29	2005-06-07	Merck & Co., Inc.	Heterocyclic amide compounds as cell adhesion inhibitors
AU8059598A (en) *	1998-06-11	1999-12-30	Merck & Co., Inc.	Heterocyclic amide compounds as cell adhesion inhibitors
JO3371B1 (ar)	2013-07-26	2019-03-13	Ferring Bv	ناهضات مستقبل فاسوبريسين 2

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL6509712A (sv) *	1964-07-27	1966-01-28
CH495957A (de) *	1966-09-15	1970-09-15	Ceskoslovenska Akademie Ved	Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids
NL167323C (nl) *	1970-09-26	1981-12-16	Organon Nv	Werkwijze ter bereiding van een psychofarmacologisch preparaat.
US4261980A (en) *	1980-05-16	1981-04-14	Vega Laboratories, Inc.	Method for prophylaxis and/or treatment of sickle cell disease
US4399125A (en) *	1981-03-24	1983-08-16	Maurice Manning	Novel antagonists of the antidiuretic action of arginine vasopressin

1983
- 1983-04-07 DK DK153883A patent/DK153883A/da not_active Application Discontinuation
- 1983-04-11 GB GB08309736A patent/GB2121049B/en not_active Expired
- 1983-04-14 SE SE8302075A patent/SE460050B/sv not_active IP Right Cessation
- 1983-04-15 NL NL8301320A patent/NL8301320A/nl not_active Application Discontinuation
- 1983-04-19 CH CH2098/83A patent/CH653345A5/de not_active IP Right Cessation
- 1983-04-19 IT IT20677/83A patent/IT1164189B/it active
- 1983-04-19 BE BE0/210584A patent/BE896504A/fr not_active IP Right Cessation
- 1983-04-19 FR FR8306357A patent/FR2525215B1/fr not_active Expired
- 1983-04-20 DE DE19833314357 patent/DE3314357A1/de not_active Ceased
- 1983-04-20 US US06/486,863 patent/US4482486A/en not_active Expired - Fee Related
1988
- 1988-06-15 JP JP63145941A patent/JPS6485999A/ja active Pending

Also Published As

Publication number	Publication date
FR2525215B1 (fr)	1986-02-28
GB8309736D0 (en)	1983-05-18
DK153883A (da)	1983-10-21
DK153883D0 (da)	1983-04-07
BE896504A (fr)	1983-08-16
GB2121049A (en)	1983-12-14
SE460050B (sv)	1989-09-04
DE3314357A1 (de)	1983-10-27
NL8301320A (nl)	1983-11-16
SE8302075D0 (sv)	1983-04-14
IT1164189B (it)	1987-04-08
JPS6485999A (en)	1989-03-30
US4482486A (en)	1984-11-13
GB2121049B (en)	1985-04-17
CH653345A5 (de)	1985-12-31
FR2525215A1 (fr)	1983-10-21
IT8320677A0 (it)	1983-04-19

Legal Events

Date

Code

Title

Description

1995-01-31

NUG

Patent has lapsed

Ref document number: 8302075-0

Effective date: 19911108

Format of ref document f/p: F

Publication	Publication Date	Title
CO4790174A1 (es)	1999-05-31	Analogos del peptido lh-rh, sus usos y composiciones farmaceuticas que los contienen
DE3760351D1 (en)	1989-08-31	Electrostatic spraying apparatus
GB1509367A (en)	1978-05-04	Ginglymus joint implant
ES2159184T3 (es)	2001-09-16	Nueva posologia para la dmni.
AR038434A2 (es)	2005-01-12	Compuesto 14,15-dihidro-16-oxoparahercuamida y compuestos 2-desoxo de parahercuamida y marcfortina
SE8302075D0 (sv)	1983-04-14	Vasopressin-analoger
ES2143487T3 (es)	2000-05-16	1,2,4-oxadiazolil-fenoxialquilisoxazoles y su empleo como agentes antivirales.
ES2114931T3 (es)	1998-06-16	Nuevos esteres esteroidales.
ES8306767A1 (es)	1983-06-16	"metodo de preparar compuestos esteroidicos antiinflamatorios".
DE59002863D1 (de)	1993-10-28	Lysolecithinderivate zur behandlung von autoimmunerkrankungen.
ES2056153T3 (es)	1994-10-01	Expectorante que comprende un derivado hidroxialquilcisteina.
DK0565519T3 (da)	1996-09-23	Illudinanaloge som antitumormidler
JPS53145932A (en)	1978-12-19	Stable aromatic gel containing perfume
ES2133153T3 (es)	1999-09-01	Nuevos depsipeptidos ciclicos con 18 atomos de anillo, y su empleo para el combate de endoparasitos.
MX9307203A (es)	1994-07-29	COMPUESTOS ESTEROIDALES DE ACIL-3-CARBOXI-3,5-DIENO-17Ó Y 17ß -SUBSTITUIDOS.
ES8303316A1 (es)	1983-02-01	Un procedimiento para la fabricacion de un disulfuro intra ointermolecular
ES8203363A1 (es)	1982-04-01	Un procedimiento para la preparacion de 1-oxo-1h-tiazolo-( 3-2-a) pirimidina.
SG58291G (en)	1991-08-23	Anticonvulsant agents
ES472240A1 (es)	1979-10-16	Un procedimiento para la preparacion de nuevos compuestos decefalosporina
SE8200757L (sv)	1982-02-10	Biologiskt aktiva peptider
MX9303970A (es)	1994-04-29	COMPUESTOS ESTEROIDALES DE ANILLO A DE 17Ó Y 17ß-ALQUILCETONA-3-CARBOXIAROMATICO.
ATE30402T1 (de)	1987-11-15	Fuellhalter.
JPS6463342A (en)	1989-03-09	Stabilization of glutathione-containing composition
JPS5359095A (en)	1978-05-27	Preparation of 7-aminocephem cpds.
FR2691472B1 (fr)	1994-08-19	Utilisation d'un amide comme agent épaississant, agent épaississant correspondant et composition le contenant.